Generics in the United States

Generics in the United States

Summary

Generics in the United States industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

• A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and branded generics are included in our market scope. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included. Market value is evaluated at ex-factory prices. Market volume refers to the proportion of the total ethical pharmaceutical market in a country or region that is made up of generic drugs. Thus, it is a measure of the market share held by generics, rather than a direct measure of the total market volume. Regional volumes are calculated as averages of countries that comprise the region where volume data exists.
• The US generics market recorded revenues of $74.2 billion in 2023, representing a compound annual growth rate (CAGR) of 4.2% between 2018 and 2023.
• Market consumption volume increased with a CAGR of 0.3% between 2018 and 2023, to reach a total of 90.3% of total pharma volume in 2023.
• The generics market in the US is driven by regulatory support and approval processes. The US Food and Drug Administration (FDA) supports the entry of generic drugs into the market by ensuring a clear pathway for approval through the Abbreviated New Drug Application (ANDA) process.

• Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the generics market in the United States
• Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in the United States
• Leading company profiles reveal details of key generics market players’ global operations and financial performance
• Add weight to presentations and pitches by understanding the future growth prospects of the United States generics market with five year forecasts by both value and volume

• What was the size of the United States generics market by value in 2023?
• What will be the size of the United States generics market in 2028?
• What factors are affecting the strength of competition in the United States generics market?
• How has the market performed over the last five years?
• Who are the top competitors in the United States's generics market?